Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.
| Autor: | Kaback M; Glaucoma Consultants of the Capital Region, Slingerlands, New York, USA., Scoper SV, Arzeno G, James JE, Hua SY, Salem C, Dickerson JE, Landry TA, Bergamini MV |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Ophthalmology [Ophthalmology] 2008 Oct; Vol. 115 (10), pp. 1728-34, 1734.e1-2. Date of Electronic Publication: 2008 Jun 05. |
| DOI: | 10.1016/j.ophtha.2008.04.011 |
| Abstrakt: | Purpose: To compare the safety and intraocular pressure (IOP)-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination with brinzolamide 1% or timolol 0.5% alone in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). Design: Randomized, double-masked, parallel group, multicenter study. Participants: Five hundred twenty-three patients were randomized to the study treatments. Methods: Patients with OAG or OHT were recruited to the study. Qualifying eyes had IOPs of 24 to 36 mmHg at 8 am and 21 to 36 mmHg at 10 am on 2 eligibility visits after an appropriate washout period from previous treatment. Patients were assigned randomly to either brinzolamide 1%/timolol 0.5%, brinzolamide 1% (Azopt; Alcon Laboratories, Fort Worth, TX), or timolol 0.5%, dosed twice daily and were followed up while receiving therapy for 6 months. At selected sites, additional IOP measurements were performed at 12 pm, 4 pm, and 8 pm during the 2 eligibility visits, at month 3, and at month 6. Main Outcome Measure: Mean IOP. Results: Brinzolamide 1%/timolol 0.5% produced statistically significant and clinically relevant reductions from baseline ranging from 8.0 to 8.7 mmHg, which were statistically and clinically superior to that of either brinzolamide 1% (5.1-5.6 mmHg) or timolol 0.5% (5.7-6.9 mmHg). No safety concerns were identified based on an assessment of ocular and cardiovascular parameters and a review of adverse events. Conclusions: Brinzolamide 1%/timolol 05% is superior in IOP-lowering efficacy to either brinzolamide 1% or timolol 0.5%. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|